Table 1 Development of different parameters over time (SD).
| Preoperative | Postoperative | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 day | 1–2 days | 1–2 weeks | 1–2 months | 3–6 months | 1 year | 2 years | 3 years | |
| Mean SE (D) | −0.34 (2.42) n = 51 | −0.3 (1.11) n = 51 | −0.13 (1.01) n = 51 | −0.12 (1.19) n = 51 | −0.02 (1.19) n = 51 | 0.17 (1.24) n = 51 | −0.06 (1.23) n = 51 | −0.04 (1.2) n = 51 |
| Mean BCDVA >20/40 | 20/60 n = 51 | 20/32 n = 51 | 20/30 n = 51 | 20/25 n = 51 | 20/25 n = 51 | 20/25 n = 51 | 20/25 n = 51 | 20/25 n = 51 |
| 35.29% | 86.0% | 90.2% | 100% | 100% | 100% | 94.0% | 94.12% | |
| Mean ECC (cells/mm2) | 2612 (346) n = 67 | – | 2484 (332) n = 58 | 2346 (381) n = 67 | 2380 (316) n = 45 | – | – | – |
| Mean flare (photons/ms) | 10.3 (0.7) n = 68 | 17.8 (1.0) n = 68 | 17.9 (1.5) n = 67 | 11.1 (0.8) n = 63 | 9.9 (0.6) n = 37 | – | – | – |
| Mean PCO (total IOL optic) | – | – | – | – | 0.20 (0.20) n = 36 | 0.35 (0.22) n = 31 | – | 0.87 (0.57) n = 40 |
| Mean PCO (3 mm zone) | – | – | – | – | 0.11 (0.20) n = 43 | 0.31 (0.25) n = 36 | – | 0.69 (0.63) n = 40 |
| Mean PCO (CR) | – | – | – | – | 0.14 (0.21) n = 36 | 0.20 (0.29) n = 31 | – | 0.86 (0.59) n = 40 |
| Mean overlapping (%) | – | 25.0 (9.1) n = 62 | – | – | 28.6 (10.5) n = 38 | 22.5 (17.4) n = 30 | – | 25.1 (11.2) n = 40 |
SE, spherical equivalent, D, dioptre, BCDVA, best corrected distance visual acuity, ECC, endothelial cell count, PCO, posterior capsule opacification, IOL, intraocular lens, CR, capsulorhexis, n, number of eyes.